Skip to main content
. 2020 Jul 3;69(26):841–846. doi: 10.15585/mmwr.mm6926e3

TABLE 1. Self-reported demographic and baseline clinical characteristics of outpatients (N = 271) and inpatients (N = 79) with SARS-CoV-2 RT-PCR–positive test results at 14–21 days or 28–35 days after testing — academic medical centers,* United States, March–May 2020.

Characteristic No. (%)
Total (350) Outpatients (271) Inpatients (79) P-value
Median age, yrs, (IQR)
43 (32–57)
42 (31–54)
54 (36–68)
<0.001
Female sex
185 (53)
144 (53)
41 (52)
0.85
Race/Ethnicity
0.008
White, non-Hispanic
116 (33)
101 (37)
15 (19)
Black, non-Hispanic
73 (21)
51 (19)
22 (28)
Hispanic
116 (33)
82 (30)
34 (43)
Other, non-Hispanic
43 (12)
35 (13)
8 (10)
Unknown
2 (1)
2 (1)
0 (0)
Medical Insurance
0.85
Yes
289 (83)
222 (82)
67 (85)
No
45 (13)
34 (13)
11 (14)
Unknown
16 (5)
15 (6)
1 (1)
Education level
0.83
Less than college
177 (51)
135 (50)
42 (53)
Some college or more
154 (44)
119 (44)
35 (44)
Unknown
19 (5)
17 (6)
2 (3)
Annual household income
0.003
<$25,000
56 (16)
34 (13)
22 (28)
$25,000–$49,000
92 (26)
77 (28)
15 (19)
$50,000–$74,000
33 (9)
27 (10)
6 (8)
>$74,000
57 (16)
49 (18)
8 (10)
Unknown/Refused to answer
112 (32)
84 (31)
28 (35)
Underlying medical condition (334)§
Number, median (IQR)
1 (0–2)
1 (0–2)
2 (1–3)
<0.001
Any cardiac disease
100 (30)
69 (27)
31 (41)
0.019
   Hypertension
97 (29)
67 (26)
30 (39)
0.023
   Coronary artery disease
10 (3)
5 (2)
5 (7)
0.037
   Congestive heart failure
9 (3)
3 (1)
6 (8)
0.005
Any respiratory disease
65 (20)
40 (16)
25 (33)
0.001
   Asthma
55 (16)
36 (14)
19 (25)
0.022
   COPD
18 (5)
6 (2)
12 (16)
<0.001
Diabetes
51 (15)
28 (11)
23 (30)
<0.001
Obesity (BMI ≥30 kg/m2)
67 (20)
47 (18)
20 (26)
0.13
Chronic kidney disease
14 (4)
8 (3)
6 (8)
0.067
Chronic liver disease
11 (3)
5 (2)
6 (8)
0.011
Immunosuppressive condition
22 (7)
16 (6)
6 (8)
0.60
Rheumatologic/Autoimmune condition
28 (8)
20 (8)
8 (11)
0.45
Neurologic condition
16 (5)
9 (4)
7 (9)
0.041
Blood disorder
12 (4)
7 (3)
5 (7)
0.11
Psychiatric disorder
69 (21)
52 (20)
17 (23)
0.65
Ever used tobacco
104 (31)
77 (30)
27 (36)
0.36
Current tobacco use (among ever users)
17 (17)
15 (20)
2 (7)
0.23
Current alcohol use** 112 (34) 89 (35) 23 (30) 0.45

Abbreviations: BMI = body mass index; COPD = chronic obstructive pulmonary disease; IQR = interquartile range; RT-PCR = reverse transcription–polymerase chain reaction.

* Patients were sampled from 11 academic medical centers in nine states (University of Washington [Washington], Oregon Health and Sciences University [Oregon], University of California Los Angeles and Stanford University [California], Hennepin County Medical Center [Minnesota], Vanderbilt University [Tennessee], The Ohio State University [Ohio], Wake Forest University [North Carolina], Montefiore Medical Center [New York], Beth Israel Deaconess Medical Center and Baystate Medical Center [Massachusetts]).

Other non-Hispanic included two persons who reported being American Indian/Alaska Native, 25 Asian, three Native Hawaiian/Other Pacific Islander, and 18 Other; five reported both Asian and Other for race. Other race group combined because of comparatively low numbers in these groups compared with other race/ethnicity groups.

§ Excluding 16 (5%) patients who did not answer questions about underlying medical conditions; for those who answered questions about underlying conditions, some respondents were missing data on congestive heart failure (one), obesity (three), rheumatologic/autoimmune conditions (one), neurologic conditions (one), and psychiatric conditions (two); denominators used to calculate proportions of respondents with individual underlying medical conditions excluded patients who have missing data for the condition.

Unknown for 17 (14 outpatients and three inpatients); among those who had ever used tobacco products, one did not state whether they were a current tobacco user.

** Unknown for 19 (16 outpatients and three inpatients).